Načítá se...
Hydralazine and nitrates in the treatment of heart failure with reduced ejection fraction
Hydralazine and nitrate combination was the first treatment that showed improved survival of patients with heart failure with reduced left ventricular ejection fraction (HFREF) in the Vasodilator Heart Failure Trial (V‐HeFT trial) in 1986. This showed a 34% reduction of mortality at 2 years of follo...
Uloženo v:
| Vydáno v: | ESC Heart Fail |
|---|---|
| Hlavní autor: | |
| Médium: | Artigo |
| Jazyk: | Inglês |
| Vydáno: |
John Wiley and Sons Inc.
2019
|
| Témata: | |
| On-line přístup: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6676279/ https://ncbi.nlm.nih.gov/pubmed/31119890 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/ehf2.12459 |
| Tagy: |
Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!
|